Klimadinon tablets, No. 60

Klimadinon tablets, No. 60; Vegeto-vascular disorders during menopause, pre- and postmenopause (hot flashes, excessive sweating, sleep disturbances, increased nervous excitability, mood changes, apathy, etc.).

Inside, 1 tablet 2 times a day at the same time of day (morning and evening).

The tablets should be swallowed without chewing with a little water. The duration of treatment is determined by the doctor.

Active ingredient:

cimicifuga (Cimicifuga racemosa L.) rhizomes extract dry 20.0 mg (contains 2.8 mg of cimicifuga rhizomes extract native (5-10: 1, extractant ethanol 58% v / v) and lactose monohydrate 17.2 mg)

Auxiliary components:

calcium hydrogen phosphate dihydrate, potato starch, magnesium stearate, talc, titanium dioxide E 171, iron oxide yellow E 172, iron oxide red E 172, macrogol 6000, eudragit RL 30D (ammonium methacrylate copolymer (1: 2: 0.2) 1, 35 mg and sorbic acid 0.01 mg)

Hypersensitivity to the components of the drug, lactose intolerance.

Cannot be used to treat patients with estrogen-dependent tumors.

With care: liver disease, epilepsy, diseases and brain injuries (use is possible only after consulting a doctor).

Dosage form

Film-coated tablets

Manufacturer

Bionorica SE, Kerschensteinerstrasse 11-15, 92318, Neumarkt, Germany

Composition

Active ingredient:

cimicifuga (Cimicifuga racemosa L.) rhizomes extract dry 20.0 mg (contains 2.8 mg of cimicifuga rhizomes extract native (5-10: 1, extractant ethanol 58% v / v) and lactose monohydrate 17.2 mg)

Auxiliary components:

calcium hydrogen phosphate dihydrate, potato starch, magnesium stearate, talc, titanium dioxide E 171, iron oxide yellow E 172, iron oxide red E 172, macrogol 6000, eudragit RL 30D (ammonium methacrylate copolymer (1: 2: 0.2) 1, 35 mg and sorbic acid 0.01 mg)

Description

Round biconvex tablets, coated with a pink color with a brown tint.

Pharmacotherapeutic group

Anti-climacteric herbal remedy

Pharmacological properties

KlimadinonЃ has an estrogen-like effect, shows sedative properties, and has a therapeutic effect on the autonomic nervous system. The use of the drug contributes to the weakening or complete disappearance of symptoms of malaise during menopause. The therapeutic effect of KlimadinonЃ begins gradually and appears after approximately 2 weeks of treatment.

Indications for use

Vegeto-vascular disorders during menopause, pre- and postmenopause (hot flashes, excessive sweating, sleep disturbances, increased nervous excitability, mood changes, apathy, etc.).

Contraindications

Hypersensitivity to the components of the drug, lactose intolerance.

Cannot be used to treat patients with estrogen-dependent tumors.

With care: liver disease, epilepsy, diseases and brain injuries (use is possible only after consulting a doctor).

Application during pregnancy and lactation

The drug should not be used during pregnancy and lactation.

Method of administration and dosage

Inside, 1 tablet 2 times a day at the same time of day (morning and evening).

The tablets should be swallowed without chewing with a little water. The duration of treatment is determined by the doctor.

Side effects

Allergic reactions are possible.

In rare cases, the appearance of pain in the epigastric region is possible.

An increase in body weight is possible. Very rarely, there is a feeling of tension in the mammary glands and menstrual bleeding.

Overdose

Cases of overdose and intoxication are currently unknown.

Interaction with other medicinal products

Interactions with other medicinal products are currently unknown.

special instructions

The drug should not be used for more than 3 months without consulting a doctor.

When pregnancy occurs, you must stop taking the drug and consult a doctor.

When used in recommended doses, the drug does not affect the ability to drive vehicles and work with mechanisms that require increased attention.

Indication for patients with diabetes mellitus:

Patients with diabetes mellitus can take Klimadinon tablets, since a single dose of this drug contains less than 0.04 'bread units'.

Release form

Film-coated tablets. 15 tablets in a blister made of aluminum foil (bottom side) and PVC, PE, PVDC film (top side). 4, 6 blisters are placed in a folding box with instructions for use.

Storage conditions

In a dry, dark place at a temperature not exceeding 25 ? C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiration date.

Conditions of dispensing from pharmacies

Without recipe